Related Experiment Video
Updated: Jun 18, 2026

Nerve Excitability Assessment in Chemotherapy-induced Neurotoxicity
Published on: April 26, 2012
Sensory-motor axonal peripheral neuropathy in an advanced breast cancer patient treated with ixabepilone
Joaquim Bosch-Barrera1, Jaime Espinós, Asier Gómez-Ibáñez
1Department of Oncology, Clínica Universidad de Navarra, Pamplona, Navarra, Spain. jbosch@unav.es
Abstract:
Ixabepilone is a novel microtubule-stabilising agent used as monotherapy or in combination with capecitabine to treat taxane- and anthracycline-refractory breast cancer. We report the case of a patient who experienced an unusual motor neuropathy after the first cycle. This is a very uncommon secondary effect, but it must be taken into account as a possible complication of treatment with ixabepilone.
Related Concept Videos
Peripheral Artery Disease IV: Nursing Management
Diabetic Neuropathy
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Peripheral Artery Disease V: Postoperative Nursing Management
Treatment Resistant Cancers
Peripheral Artery Disease I: Introduction